Endava (NYSE:DAVA) will post its quarterly earnings results before the market opens on Wednesday, May 19th. Analysts expect Endava to post earnings of $0.25 per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.
Endava (NYSE:DAVA) last posted its earnings results on Tuesday, February 16th. The company reported $29.00 earnings per share for the quarter, topping analysts’ consensus estimates of $0.23 by $28.77. Endava had a return on equity of 6.07% and a net margin of 3.70%. The firm had revenue of $139.01 million for the quarter, compared to the consensus estimate of $136.41 million. On average, analysts expect Endava to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
DAVA stock opened at $90.00 on Tuesday. Endava has a fifty-two week low of $43.52 and a fifty-two week high of $94.95. The business’s 50 day moving average price is $86.78 and its two-hundred day moving average price is $79.48. The company has a market capitalization of $4.77 billion, a price-to-earnings ratio of 300.00, a price-to-earnings-growth ratio of 3.59 and a beta of 0.93.
Endava Company Profile
Endava plc provides technology services for clients in the consumer products, healthcare, logistics, and retail verticals in Europe, Latin America, and North America. It offers technology and digital advisory services for financial services, healthcare, manufacturing, retail and consumer, business and support services, and TMT sectors; IT strategies; business analysis services in payments, financial services, asset and wealth management, insurance, telecommunications, and digital media areas; program management services; digital product strategy services; and architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
Read More: Balanced Fund
Receive News & Ratings for Endava Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endava and related companies with MarketBeat.com's FREE daily email newsletter.